Last mentioned: Mar 21, 2026
Potential Settlement
Typical timeframe for securities class actions to reach settlement or dismissal phases.
Formal Complaint Filing
Anticipated filing of detailed class action complaints if investigations yield actionable evidence.
Lead Plaintiff Deadline
Expected 60-day window for investors to move the court to serve as lead plaintiff.
Lead Plaintiff Deadline
The final date for investors to petition the court to lead the litigation against Enphase.
Investigation Announced
Rosen Law Firm officially launches investigation into potential securities fraud at SMCI.
Investigation Launch
Rosen Law Firm issues public notices regarding probes into Barclays and Vital Farms.
Institutional Sell-off
Victory Capital Management Inc. reduces its holdings in Super Micro Computer shares.
Institutional Investment
Integrated Financial Solutions Inc. makes a new $3.31 million investment in SMCI.
Lawsuit Announcement
Rosen Law Firm officially announces the filing of the class action and the lead plaintiff deadline.
Class Period Ends
The final date of the period during which investors are eligible to join the class.
Class Period Begins
The start date for the alleged misstatements or omissions by Enphase Energy.
Rosen Law Firm has initiated an investigation into Super Micro Computer, Inc. (SMCI) regarding potential securities claims on behalf of shareholders. The probe focuses on allegations that the company may have issued materially misleading business information to the public.
Rosen Law Firm has initiated dual investigations into potential securities law violations by global banking giant Barclays PLC and ethical food producer Vital Farms, Inc. These probes signal a heightened period of scrutiny for public companies regarding disclosure transparency and fiduciary duties.
Rosen Law Firm has initiated a securities class action lawsuit against Enphase Energy, Inc. (ENPH) for alleged misstatements during a critical 2025 growth period. Investors who purchased securities between April and October 2025 have until April 20, 2026, to seek lead plaintiff status in the litigation.
Corcept Therapeutics (NASDAQ: CORT) is the target of a class action lawsuit alleging securities fraud between October 2024 and December 2025. The Rosen Law Firm is leading the litigation, which centers on claims that the company misled investors regarding its business operations and regulatory compliance. This legal challenge marks a critical period of scrutiny for the pharmaceutical firm's corporate governance and public disclosure practices.
The Rosen Law Firm has initiated a securities class action investigation against PayPal Holdings, Inc., following a significant stock drop linked to the company's February 2026 financial disclosures. The firm is urging affected investors to secure legal counsel before the upcoming lead plaintiff deadline to address allegations of materially false or misleading business statements.
This page surfaces every story mentioning Rosen Law Firm across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Rosen Law Firm was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |